FFA
NTLA icon

Farther Finance Advisors’s Intellia Therapeutics NTLA Stock Holding History

Farther Finance Advisors’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$25.9K Buy
2,144
+1,594
+290% +$19.9K ﹤0.01% 3942
2026
Q2 		$9.31K Sell
550
-684
-55% -$9.57K ﹤0.01% 4469
2026
Q1 		$16.4K Buy
1,234
+974
+375% +$12.4K ﹤0.01% 3788
2025
Q4 		$2.34K Buy
260
+177
+213% +$2.44K ﹤0.01% 4630
2025
Q3 		$1.43K Hold
83
– – ﹤0.01% 4256
2025
Q2 		$779 Sell
83
-40
-33% -$328 ﹤0.01% 3953
2025
Q1 		$819 Buy
123
+40
+48% +$404 ﹤0.01% 3676
2024
Q4 		$968 Sell
83
-35
-30% -$546 ﹤0.01% 3260
2024
Q3 		$2.42K Sell
118
-5
-4% -$115 ﹤0.01% 2930
2024
Q2 		$2.76K Buy
123
+29
+31% +$690 ﹤0.01% 2659
2024
Q1 		$2.56K Sell
94
-82
-47% -$2.28K ﹤0.01% 2385
2023
Q4 		$5.37K Buy
176
+162
+1,157% +$4.66K ﹤0.01% 1936
2023
Q3 		$443 Sell
14
-4
-22% -$155 ﹤0.01% 2303
2023
Q2 		$734 Hold
18
– – ﹤0.01% 2049
2023
Q1 		$671 Hold
18
– – ﹤0.01% 1931
2022
Q4 		$628 Buy
+18
New +$856 ﹤0.01% 1786

Other funds holding NTLA

VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
GWM
GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Farther Finance Advisors's NTLA Position: Q3 2026 in Review

Farther Finance Advisors increased its Intellia Therapeutics (NTLA) stake by 290% in Q3 2026, buying an estimated $19.9K and bringing the position to 2,144 shares worth $25.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3942.

Farther Finance Advisors first reported a position in NTLA in Q4 2022 and has held it in 16 quarters since. 6 funds tracked by Wall St. Rank hold NTLA as of Q3 2026.

  • Farther Finance Advisors held 2,144 shares of Intellia Therapeutics worth $25.9K as of Q3 2026.
  • Farther Finance Advisors bought 1,594 Intellia Therapeutics shares in Q3 2026, an estimated $19.9K.
  • Intellia Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #3942 holding.
  • Farther Finance Advisors first reported a position in Intellia Therapeutics in Q4 2022 and has held it in 16 quarters since.
  • 6 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.